We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Researchers Create Novel DNA-Repair Enzyme

By Biotechdaily staff writers
Posted on 23 May 2002
Data from the Human Genome Project has been used by scientists to synthesize a human DNA repair enzyme. More...
The human genome was scanned to find sequences similar to those known to code for DNA repair enzymes, known as glycosylases, in E coli bacteria.

After identifying two such sequences, researchers from the University of Texas Medical Branch (Galveston, USA; www.utmb.edu) and colleagues from other institutions then used one of them to produce a previously unknown protein, which proved able to function as a glycosylase when tested on damaged DNA in vitro. This glycosylase, which they named NEH1, is the first to be discovered of a new class of mammalian DNA repair enzymes. This research was reported in the March 19, 2002 issue of the Proceedings of the National Academy of Sciences.

NEHI possesses two characteristics that enhance its effectiveness in repairing oxidative damage. First, NEH1 may work on the small, critical portion of human DNA that is actually active. Second, cells produce far more NEH1 when their DNA is replicating, as if to catch any errors introduced by oxidative stress before they are passed on to the next generation.

"This replication coupling is fascinating,” Mitra says, "and so is the way in which the repair of active genes is different from the repair of the bulk of the genome.” The researchers also examined human tissues for NEH1, seeking to determine its relative level in different organs of the body. They found that messenger RNA coding for NEH1 was highest in the liver, pancreas and thymus.




Related Links:
University of Texas Medical Branch

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.